CDK4/6-IN-2 |
Catalog No.GC35633 |
CDK4/6-IN-2는 특허 US20180000819A1, 화합물 1에서 추출된 강력한 CDK4 및 CDK6 억제제이며, CDK4 및 CDK6에 대해 각각 2.7 및 16 nM의 IC50을 갖습니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1800506-48-2
Sample solution is provided at 25 µL, 10mM.
CDK4/6-IN-2 is a potent CDK4 and CDK6 inhibitor extracted from patent US20180000819A1, Compound 1, has IC50s of 2.7 and 16 nM for CDK4 and CDK6, respectively[1]. CDK4|2.7 nM (IC50)|CDK6|16 nM (IC50)
CDK4/6-IN-2 inhibits H358, H441, PC3, MV-4-11, JeKo-1, SW780, and HGC-27 cells with IC50s of 290.9, 147.8, 260.5, 139, 36.98, 162.5, and 316.4 nM, respectively[1].
[1]. Frank Wu, et al. Kinase inhibitor and use thereof. US20180000819A1.
Average Rating: 5
(Based on Reviews and 26 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *